Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 22 December 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne, Inc. (NASDAQ: BLLN) is still in the “fresh IPO” phase where price discovery happens in public—loudly. On December 22, 2025, the molecular diagnostics company’s shares were trading at $97.36, down about 5.1% on the session, after opening above $103 and swinging through a $96.61–$103.85 intraday range. There wasn’t a new company press release dated today that materially changed the story. Instead, BLLN’s move looks like part of the normal churn that follows a high-profile debut: early enthusiasm, analyst initiations, earnings/guidance digestion, and then a tug-of-war between “this could be huge” and “but how much is already priced in?” Below
22 December 2025
·····
Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors, Inc. (NASDAQ: ASO) stock traded lower on Monday, December 22, 2025, as a mix of sector headlines and company-specific fundamentals collided—again reminding investors that retail is where macro nerves go to get amplified. As of the latest available trading data, ASO was around $51.21, down about 4.64% on the day, with a market cap near $3.45 billion. The down move comes even though Academy’s most recent quarterly report showed improving profitability and a narrowed full-year outlook. So what’s driving the weakness today, what do the latest forecasts say, and how is Wall Street positioning into 2026?
22 December 2025
······
Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Stock (NYSE: KSS) Drops on Dec. 22, 2025: Short Interest Climbs, Analyst Targets Lag After a Volatile 2025 Rally

Kohl’s Corporation stock (NYSE: KSS) sold off sharply in Monday trading on December 22, 2025, underscoring just how jumpy this name remains after a meme-stock-flavored year. By early afternoon, KSS traded around $21.6, down roughly 7% on the session, after opening near $23.20 and touching an intraday low around $21.69. Volume was a little over 2.2 million shares at the time of the quote—active, but not the kind of panic stampede you’d see in a full-blown capitulation day. StockAnalysis+1 If you’re trying to make sense of Kohl’s stock right now, the market’s “story stack” is basically three layers deep: Here’s
22 December 2025
·····
Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy Stock Drops on Offshore Wind Lease Pause: What Investors Should Know About NYSE:D, CVOW, Dividends and the 2026 Outlook

Dominion Energy, Inc. (NYSE: D) stock took an uncharacteristically sharp hit on December 22, 2025, sliding roughly 5%–6% into the mid‑$50s as Washington put the brakes on the U.S. offshore wind buildout—right in the middle of construction. Reuters+1 Utilities usually trade like slow-moving planets: predictable gravity, modest drama. Today was different. The reason wasn’t earnings, a dividend cut, or a surprise rate case loss. It was policy risk colliding with a $11-ish billion megaproject that Dominion has positioned as a cornerstone of Virginia’s energy future. Below is what happened, what the key headlines and analysts are saying as of 22.12.2025,
22 December 2025
·····
Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Stock (CVX) Climbs on Venezuela Supply Risks: Latest News, Forecasts and Outlook (Dec. 22, 2025)

Chevron Corporation’s stock was higher Monday as a fresh wave of Venezuela-related shipping headlines pushed oil prices up and put energy names back in focus during a holiday-shortened week. As of midday Monday, Chevron (NYSE: CVX) traded around $150, up roughly 1.6% on the session. MarketWatch reported Chevron was also a notable driver of the Dow’s intraday gain, reflecting the stock’s outsized influence inside the price-weighted index. MarketWatch Below is what’s moving Chevron today, what analysts and markets are watching next, and how the company’s capital-return and spending plans frame the longer-term bull and bear cases for CVX. Why Chevron
22 December 2025
····
Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

Edgewise Therapeutics (EWTX) Stock News Today: What’s Driving the Volatility, Analyst Forecasts, and Key Catalysts (Dec. 22, 2025)

December 22, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight as its stock price whipsaws following a sharp late-week surge and a fresh round of market commentary that mixes optimism about the company’s muscle-disease pipeline with familiar concerns about cash burn in a pre-revenue biotech. As of 18:40 UTC on Dec. 22, EWTX traded at $21.29, after swinging between $27.77 and $21.18 intraday, with volume running well above a million shares. Below is a complete, news-style breakdown of the current coverage and forecasts circulating on Dec. 22, 2025, plus the trial and business milestones investors are
22 December 2025
·····
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025)

Twist Bioscience Corporation (NASDAQ: TWST) is ending 2025 with something investors in “tools + genomics” names haven’t always been able to count on: momentum that’s tied to multiple moving pieces—new product launches, partner-driven workflow wins, and a profitability narrative that’s finally getting sharper edges. On December 22, 2025, TWST shares were trading around $34.26, up about 5.4% on the session at the time of writing (midday U.S. trading). MarketScreener That pop isn’t happening in a vacuum. Over the past few weeks, the company has stacked up incremental catalysts—from a fresh licensing deal touching NGS and hot-start PCR, to product expansion
22 December 2025
·····
Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat (VSAT) Stock Today: Price Jumps as ViaSat-3 Expansion, Ka-Band Defense Network, and Analyst Forecasts Shape 2026 Outlook (Dec. 22, 2025)

Viasat, Inc. (NASDAQ: VSAT) shares were trading around $36.16 on Monday, December 22, 2025, up roughly 7% from the prior close—another sharp move in what has been a highly eventful year for the satellite communications company and its investors. MarketScreener The latest momentum comes as Wall Street continues to weigh three big themes around Viasat stock: Below is a complete, up-to-date breakdown of the most relevant news, forecasts, and analyst thinking available as of Dec. 22, 2025. Viasat stock price on Dec. 22, 2025: what the market is doing right now By midday on Dec. 22, VSAT was quoted near
22 December 2025
·····
Texas Instruments (TXN) Stock Today (Dec. 22, 2025): Sherman Fab Momentum Meets a Split Wall Street

Texas Instruments (TXN) Stock Today (Dec. 22, 2025): Sherman Fab Momentum Meets a Split Wall Street

Texas Instruments Incorporated (NASDAQ: TXN) is starting the holiday-shortened week with a modest rebound, as investors balance a major U.S. manufacturing milestone against lingering questions about the pace of demand recovery and what that means for margins. On Monday, Dec. 22, 2025, TXN was trading around $179 (up roughly 1.5% on the day), with the session’s range reported around $177.97 to $179.90. Investing.com+1 That price action leaves TXN still well below its 52-week high near $221.69, while sitting comfortably above the 52-week low near $139.95—a reminder that 2025 has been a year of big swings for “foundational” chipmakers tied to
22 December 2025
·····
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is having one of those classic biotech days where the market starts acting like it can see the future. On Monday, December 22, 2025, ZBIO surged roughly 14% and traded around $41.23 by early afternoon Eastern time—after touching a fresh all-time high near $41.67, according to multiple market data reports. MarketBeat+1 The timing isn’t subtle: Zenas is approaching a pivotal clinical-data moment for its lead asset obexelimab, and Wall Street research desks are increasingly framing the stock as a near-term catalyst setup—high potential reward, high potential whiplash. Below is a full roundup of the news,
22 December 2025
·····
Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding (PSNY) Stock Jumps After New Funding: Today’s News, Forecasts, and Analyst Views (Dec. 22, 2025)

Polestar Automotive Holding UK PLC (NASDAQ: PSNY) is back in the spotlight on Monday, December 22, 2025, as investors react to a fresh liquidity package anchored by its majority owner Geely—plus new bank money and a debt-to-equity conversion. By midday in New York, PSNY stock traded around $14.18, up roughly 10.9% from the prior close after opening near $12.94 and swinging between $12.80 and $14.39.Swedish newswire coverage also noted the stock popped at the open following the weekend’s financing headlines. Omni What’s driving the move is not one announcement, but a sequence of balance-sheet and funding actions over the past
22 December 2025
·····
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion (including debt). Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2 With the deal now public, the CWAN story shifts from the usual quarterly beat/miss drama to a more deal-driven narrative: merger timelines, regulatory approvals, a “go-shop” window for competing bids, and whether the stock trades at (or below) the
22 December 2025
·····
1 … 112 113 114 115 116 … 282

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop